Modulation of anti-angiogenic activity using ultrasound-activated nutlin-loaded piezoelectric nanovectors

Özlem Şen1, Attilio Marino1, Carlotta Pucci1

  • 1Istituto Italiano di Tecnologia, Smart Bio-Interfaces, Viale Rinaldo Piaggio 34, 56025, Pontedera, Italy.

Materials Today. Bio
|January 10, 2022
PubMed

Insights

This study demonstrates that piezoelectric nanoparticles loaded with nutlin-3a can remotely inhibit tumor angiogenesis. Ultrasound stimulation of these nanoparticles effectively reduces endothelial cell migration and vessel formation, offering a novel anti-cancer therapy.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Angiogenesis is vital for tumor growth, metastasis, and invasion.
  • Anti-angiogenic therapies aim to inhibit tumor vascularization.
  • Nanotechnology provides tools for targeted delivery of anti-angiogenic agents.

Purpose of the Study:

  • To investigate the anti-angiogenic potential of nutlin-3a-loaded ApoE-functionalized polymeric piezoelectric nanoparticles.
  • To evaluate the remote activation of these nanoparticles using ultrasound stimulation.
  • To assess the impact on human cerebral microvascular endothelial cells.

Main Methods:

  • Loading nutlin-3a into ApoE-functionalized polymeric piezoelectric nanoparticles.
  • Utilizing ultrasound to stimulate the nanoparticles.
  • Assessing the effects on endothelial cell tubular formation, migration, and invasion.
  • Measuring angiogenic growth factor expression.

Main Results:

  • Nutlin-3a-loaded piezoelectric nanoparticles inhibited angiogenic behavior in endothelial cells.
  • Ultrasound stimulation remotely activated the anti-angiogenic effect.
  • Disruption of tubular vessel formation, decreased cell migration and invasion observed.
  • Inhibition of tumor-induced angiogenic growth factors confirmed.

Conclusions:

  • Remotely activated piezoelectric nanoparticles offer a promising strategy to inhibit tumor-induced angiogenesis.
  • This approach could lead to novel therapeutic strategies for cancer treatment.
  • Targeted delivery and activation of anti-angiogenic agents show significant potential.